Pelabresib Plus Jakafi Maintains Efficacy in JAK-Naive Myelofibrosis
Adding pelabresib to a JAK inhibitor may improve multiple aspects of myelofibrosis, including spleen size, symptoms and bone marrow fibrosis.
Adding pelabresib to a JAK inhibitor may improve multiple aspects of myelofibrosis, including spleen size, symptoms and bone marrow fibrosis.
Before I underwent surgery to remove tumors on several organs, I was told it was the only way to determine what cancer I had.
In some patients with head and neck cancer, those who require dental care after cancer treatment may face financial burdens because of out-of-pocket costs.
The scale and complexity of primary care means there isn’t always a reliable system in place to support nurses when speaking up.
Aims This study aims to identify the impact of climate change anxiety and asthma control on asthmatics’ quality of life and examine the moderating role…
Lunresertib plus camonsertib showed promising efficacy in advanced endometrial and platinum-resistant ovarian cancers, with ORRs of 25.9% and 37.5%, respectively.
Commentary on: McCluskey A, Watson C, Nugent L, et al . ‘Sometimes You Have No Choice but to Give Them Medication’: Experiences of Nurses Caring…
Commentary on : Kata A, Dillon EC, Christina Keny RN, et a l.‘There’s So Much That They’re Enduring’: Experiences of Older Adults Undergoing Major Elective…
Aim To capture older people’s, informal caregivers’ and health professionals’ ideas on potential interventions for empowering older people and informal caregivers in transitional care decision-makin…
The patient cohorts that will be eligible for vaccination under the spring 2025 Covid-19 programme have been confirmed.
CURE® provides a space that highlights the voices of patients with cancer, survivors, caregivers, and advocates. Read personal stories on CURE’s blog page.